Jane works on business development and corporate strategy for Life Edit.
Prior to Life Edit, Jane worked in business development at Alexion Pharmaceuticals (now AstraZeneca) and in life science management consulting at L.E.K. Consulting.
Jane received her PhD in Biomedical Science from the University of California, San Diego focusing on the role of integrin signaling in regulatory T cell suppression.
.svg)
.svg)
To rewrite the future by curing disease, making any edit, anywhere.
To pave the way to faster, safer, gene editing therapeutics that cure disease and improve patient lives.
We’re guided by curiosity, rigor, and integrity. We believe in discovery and unlimited potential. We care about science and the lives of patients.
